Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
104.55-2.57 (-2.40%)
At close: 04:04PM EDT
109.77 +5.22 (+4.99%)
After hours: 07:51PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 267 6131

IndustryMedical Devices
Full-time employees19,500

Key executives

NameTitlePayExercisedYear born
Mr. Bryan C. HansonChairman, Pres & CEO3.33MN/A1967
Mr. Suketu P. UpadhyayExec. VP & CFO1.62MN/A1969
Mr. Ivan TornosChief Operating Officer1.68MN/A1976
Mr. Sang YiGroup Pres of Asia Pacific1.22MN/A1962
Mr. Wilfred van ZuilenPres of Europe, Middle East & Africa659.58kN/AN/A
Mr. Paul A. StellatoVP, Controller & Chief Accounting OfficerN/AN/A1975
Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerN/AN/AN/A
Mr. Zeeshan TariqSr. VP & Chief Information OfficerN/AN/AN/A
Ms. Keri P. MattoxChief Communications & Admin. Officer and Sr. VP of Investor RelationsN/AN/AN/A
Mr. Chad F. PhippsSr. VP, Gen. Counsel & Sec.N/AN/A1972
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Corporate governance

Zimmer Biomet Holdings, Inc.’s ISS governance QualityScore as of 28 September 2022 is 3. The pillar scores are Audit: 9; Board: 5; Shareholder rights: 3; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.